Insider · CIK 0001656125
Eric Francois
Files at CERO (CERO THERAPEUTICS HOLDINGS, INC.). First filing -, latest -.
Eric Francois files SEC Form 4 as director at CERO (CERO THERAPEUTICS HOLDINGS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Eric Francois has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | CERO CERO THERAPEUTICS HOLDINGS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +1,823,278 | $0.00 | $0 | 1,823,278 | Apr 21, 2026 |
Questions about Eric Francois
Answered from the filings on this page, as of the latest one.
Is Eric Francois buying or selling?
Eric Francois has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Eric Francois's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Eric Francois has 0.
Where does Eric Francois file Form 4?
Eric Francois has filed Form 4 at CERO (CERO THERAPEUTICS HOLDINGS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.